Nektar Therapeutics (NKTR) Prepaid Assets (2010 - 2026)
Nektar Therapeutics (NKTR) recorded quarterly Prepaid Assets of $20.4 million in Q1 2026, little changed quarter-over-quarter from $20.5 million in Q4 2025, and up 81.16% on a YoY basis from $11.3 million in Q1 2025.
Nektar Therapeutics (NKTR) Prepaid Assets (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $20.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 81.16% year-over-year to $20.4 million; the TTM figure through Mar 2026 stood at $20.4 million (up 81.16% YoY), while the FY2025 annual figure was $20.5 million, up 238.18% from the prior year.
- Prepaid Assets was $20.4 million for Q1 2026 at Nektar Therapeutics, roughly flat from $20.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $22.5 million in Q3 2022 to a low of $6.1 million in Q4 2024.
- Historically, Prepaid Assets has averaged $13.3 million across 5 years, with a median of $11.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets sank 59.87% in 2023, then surged 238.18% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $15.8 million in 2022, then tumbled by 38.14% to $9.8 million in 2023, then plunged by 37.97% to $6.1 million in 2024, then soared by 238.18% to $20.5 million in 2025, then slipped by 0.38% to $20.4 million in 2026.
- The last three Prepaid Assets figures came in at $20.4 million (Q1 2026), $20.5 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.44 Mn |
| Dec 31, 2025 | 20.51 Mn |
| Sep 30, 2025 | 11.15 Mn |
| Jun 30, 2025 | 10.66 Mn |
| Mar 31, 2025 | 11.28 Mn |
| Dec 31, 2024 | 6.07 Mn |
| Sep 30, 2024 | 8.93 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 10.74 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 9.60 Mn |
| Mar 31, 2023 | 11.01 Mn |
| Dec 31, 2022 | 15.81 Mn |
| Sep 30, 2022 | 22.51 Mn |
| Jun 30, 2022 | 19.25 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 23.33 Mn |
| Sep 30, 2021 | 20.73 Mn |
| Jun 30, 2021 | 12.60 Mn |